Drug Importation
Commentary
A Year Later, Florida’s Drug Importation Plan Is Misguided As Ever
When president-elect Donald Trump joked about making Canada the 51st state, he had an unlikely supporter: Bernie Sanders. “Does that mean that we can adopt the Canadian health care system and . . . lower the cost of prescription drugs,” the Vermont senator wrote on X. “I’m all for it.” ...
Commentary
Drug price controls hurt patients
Costly Imported Medicines Leave Patients Vulnerable
Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Blog
The Fentanyl Resurgimiento— A Drug Like No Other
On January 11, 2023, Dr. Rahul Gupta, the Director of the White House Office of National Drug Control Policy (ONDCP) declared a small victory. He reported new figures from the Center for Disease Control estimating that nationally there was a 2.57 percent decrease in the number of fatal drug overdoses for ...
Commentary
Diversifying America’s supply chains point to a more prosperous economic future
Rep. Cathy McMorris Rodgers, R-Wash., the chair of the powerful House Energy and Commerce Committee, recently warned that the United States is “dangerously dependent” on Chinese supply chains, especially for the raw materials used to make medicines. Her statement reflects the genuine worries of industry experts and ordinary Americans. If ...
Commentary
What Is the Value of the Interchangeability Designation for a Biosimilar?
By Wayne Winegarden, Robert Popovian & Peter Pitts Biosimilars, to date, have achieved the promise of reducing prices and drug spending in the United States. The unquestioned safety and efficacy of biosimilars have given providers, patients, and employers, amongst many others, the confidence that savings will be even more robust as we ...
Commentary
The FDA and Death by Dietary Supplement
The wife of California Republican congressman Tom McClintock, Lori McClintock, died of dehydration due to gastroenteritis caused by “adverse effects of white mulberry leaf ingestion,” according to a just-released coroner’s report. That herb is just one of many dubious and potentially life-threatening herbal remedies and other dietary supplements on the market ...
Commentary
Don’t Fall Prey to Five Common Healthcare Myths
President-elect Barack Obama has promised to make healthcare reform a top priority. But in order to follow through, Obama and lawmakers on Capitol Hill must reject some longstanding misconceptions about health care in this country. Here are five such myths. Each is widely repeated, deeply held – and dead ...
Commentary
Drug Importation Doesn’t Save Money — It Costs Lives
Proponents of prescription-drug importation notched a victory last week. The Senate Health, Education, Labor, and Pensions Committee green-lit a bill that would enable individuals to import medicines from Canada in the name of lowering out-of-pocket costs. It’s not something Americans should welcome or support. Drugs imported from outside the United States will ...
Commentary
Drug Importation Programs Come At Too High a Cost
Lawmakers in Colorado are trying to open their state’s borders to prescription drugs from abroad. In 2019, they green-lit imports from Canada. They’re still working on a plan to implement that policy that can garner federal approval. Then last week, legislators approved a bill that would allow Coloradans to import prescription drugs ...
Drug Importation
NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and ...
A Year Later, Florida’s Drug Importation Plan Is Misguided As Ever
When president-elect Donald Trump joked about making Canada the 51st state, he had an unlikely supporter: Bernie Sanders. “Does that mean that we can adopt the Canadian health care system and . . . lower the cost of prescription drugs,” the Vermont senator wrote on X. “I’m all for it.” ...
Drug price controls hurt patients
Costly Imported Medicines Leave Patients Vulnerable
Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
The Fentanyl Resurgimiento— A Drug Like No Other
On January 11, 2023, Dr. Rahul Gupta, the Director of the White House Office of National Drug Control Policy (ONDCP) declared a small victory. He reported new figures from the Center for Disease Control estimating that nationally there was a 2.57 percent decrease in the number of fatal drug overdoses for ...
Diversifying America’s supply chains point to a more prosperous economic future
Rep. Cathy McMorris Rodgers, R-Wash., the chair of the powerful House Energy and Commerce Committee, recently warned that the United States is “dangerously dependent” on Chinese supply chains, especially for the raw materials used to make medicines. Her statement reflects the genuine worries of industry experts and ordinary Americans. If ...
What Is the Value of the Interchangeability Designation for a Biosimilar?
By Wayne Winegarden, Robert Popovian & Peter Pitts Biosimilars, to date, have achieved the promise of reducing prices and drug spending in the United States. The unquestioned safety and efficacy of biosimilars have given providers, patients, and employers, amongst many others, the confidence that savings will be even more robust as we ...
The FDA and Death by Dietary Supplement
The wife of California Republican congressman Tom McClintock, Lori McClintock, died of dehydration due to gastroenteritis caused by “adverse effects of white mulberry leaf ingestion,” according to a just-released coroner’s report. That herb is just one of many dubious and potentially life-threatening herbal remedies and other dietary supplements on the market ...
Don’t Fall Prey to Five Common Healthcare Myths
President-elect Barack Obama has promised to make healthcare reform a top priority. But in order to follow through, Obama and lawmakers on Capitol Hill must reject some longstanding misconceptions about health care in this country. Here are five such myths. Each is widely repeated, deeply held – and dead ...
Drug Importation Doesn’t Save Money — It Costs Lives
Proponents of prescription-drug importation notched a victory last week. The Senate Health, Education, Labor, and Pensions Committee green-lit a bill that would enable individuals to import medicines from Canada in the name of lowering out-of-pocket costs. It’s not something Americans should welcome or support. Drugs imported from outside the United States will ...
Drug Importation Programs Come At Too High a Cost
Lawmakers in Colorado are trying to open their state’s borders to prescription drugs from abroad. In 2019, they green-lit imports from Canada. They’re still working on a plan to implement that policy that can garner federal approval. Then last week, legislators approved a bill that would allow Coloradans to import prescription drugs ...
NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and ...
